Literature DB >> 26425393

Phenylketonuria Pathophysiology: on the Role of Metabolic Alterations.

Patrícia Fernanda Schuck1, Fernanda Malgarin1, José Henrique Cararo1, Fabiola Cardoso2, Emilio Luiz Streck3, Gustavo Costa Ferreira2.   

Abstract

Phenylketonuria (PKU) is an inborn error of phenylalanine (Phe) metabolism caused by the deficiency of phenylalanine hydroxylase. This deficiency leads to the accumulation of Phe and its metabolites in tissues and body fluids of PKU patients. The main signs and symptoms are found in the brain but the pathophysiology of this disease is not well understood. In this context, metabolic alterations such as oxidative stress, mitochondrial dysfunction, and impaired protein and neurotransmitters synthesis have been described both in animal models and patients. This review aims to discuss the main metabolic disturbances reported in PKU and relate them with the pathophysiology of this disease. The elucidation of the pathophysiology of brain damage found in PKU patients will help to develop better therapeutic strategies to improve quality of life of patients affected by this condition.

Entities:  

Keywords:  brain; hyperphenylalaninemia; metabolic alterations; phenylalanine; phenylketonuria

Year:  2015        PMID: 26425393      PMCID: PMC4567221          DOI: 10.14336/AD.2015.0827

Source DB:  PubMed          Journal:  Aging Dis        ISSN: 2152-5250            Impact factor:   6.745


  95 in total

Review 1.  Role of iron in neurodegenerative disorders.

Authors:  Daniela Berg; Moussa B H Youdim
Journal:  Top Magn Reson Imaging       Date:  2006-02

Review 2.  Micronutrient status in phenylketonuria.

Authors:  M Robert; J C Rocha; M van Rijn; K Ahring; A Bélanger-Quintana; A MacDonald; K Dokoupil; H Gokmen Ozel; A M Lammardo; P Goyens; F Feillet
Journal:  Mol Genet Metab       Date:  2013-09-19       Impact factor: 4.797

3.  In vitro localization of the protein synthesis defect associated with experimental phenylketonuria.

Authors:  M A Elsliger; G R Thériault; D Gauthier
Journal:  Neurochem Res       Date:  1989-01       Impact factor: 3.996

4.  Oxysterol changes along with cholesterol and vitamin D changes in adult phenylketonuric patients diagnosed by newborn mass-screening.

Authors:  Hironori Nagasaka; Yoshiyuki Okano; Akihiko Kimura; Tatsuki Mizuochi; Yoshitami Sanayama; Tomozumi Takatani; Saori Nakagawa; Eri Hasegawa; Ken-ichi Hirano; Hiroshi Mochizuki; Toshihiro Ohura; Mika Ishige-Wada; Hiromi Usui; Tohru Yorifuji; Hirokazu Tsukahara; Satoshi Hirayama; Akira Ohtake; Susumu Yamato; Takashi Miida
Journal:  Clin Chim Acta       Date:  2012-11-17       Impact factor: 3.786

5.  Experimental hyperphenylalaninemia provokes oxidative stress in rat brain.

Authors:  Martine E Kienzle Hagen; Carolina D Pederzolli; Angela M Sgaravatti; Raquel Bridi; Moacir Wajner; Clóvis M D Wannmacher; Angela T S Wyse; Carlos S Dutra-Filho
Journal:  Biochim Biophys Acta       Date:  2002-04-24

6.  Visual functions in phenylketonuria-evaluating the dopamine and long-chain polyunsaturated fatty acids depletion hypotheses.

Authors:  Gwendolyn Gramer; Birgit Förl; Christina Springer; Petra Weimer; Gisela Haege; Friederike Mackensen; Edith Müller; Hans Eberhard Völcker; Georg Friedrich Hoffmann; Martin Lindner; Hermann Krastel; Peter Burgard
Journal:  Mol Genet Metab       Date:  2012-10-30       Impact factor: 4.797

7.  Effect of short- and long-term exposition to high phenylalanine blood levels on oxidative damage in phenylketonuric patients.

Authors:  Angela Sitta; Alethéa G Barschak; Marion Deon; Amanda T Barden; Giovana B Biancini; Paula R Vargas; Carolina F de Souza; Cristina Netto; Moacir Wajner; Carmen R Vargas
Journal:  Int J Dev Neurosci       Date:  2009-01-20       Impact factor: 2.457

8.  Phenylketonuria: High plasma phenylalanine decreases cerebral protein synthesis.

Authors:  Marieke Hoeksma; Dirk-Jan Reijngoud; Jan Pruim; Harold W de Valk; Anne M J Paans; Francjan J van Spronsen
Journal:  Mol Genet Metab       Date:  2009-02-06       Impact factor: 4.797

Review 9.  Large neutral amino acids supplementation in phenylketonuric patients.

Authors:  J C Rocha; F Martel
Journal:  J Inherit Metab Dis       Date:  2009-05-13       Impact factor: 4.982

10.  Dietary problems of phenylketonuria: effect on CNS transmitters and their possible role in behaviour and neuropsychological function.

Authors:  F Güttler; H Lou
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

View more
  26 in total

1.  Serum ischemia modified albumin is a possible new marker of oxidative stress in phenylketonuria.

Authors:  Fatemeh Keshavarzi; Mohsen Rastegar; Mahmood Vessal; Gholamreza Rafiei Dehbidi; Marjan Khorsand; Amir Hossein Ganjkarimi; Mohammad Ali Takhshid
Journal:  Metab Brain Dis       Date:  2017-12-21       Impact factor: 3.584

2.  In-silico and in-vitro investigation on the phenylalanine metabolites' interactions with hexokinase of Rat's brain mitochondria.

Authors:  Nasrin Ziamajidi; Shirin Jamshidi; Abdolvahab Ehsani-Zonouz
Journal:  J Bioenerg Biomembr       Date:  2017-03-08       Impact factor: 2.945

3.  Tanshinone I Attenuates the Effects of a Challenge with H2O2 on the Functions of Tricarboxylic Acid Cycle and Respiratory Chain in SH-SY5Y Cells.

Authors:  Marcos Roberto de Oliveira; Cristina Ribas Fürstenau; Izabel Cristina Custódio de Souza; Gustavo da Costa Ferreira
Journal:  Mol Neurobiol       Date:  2016-11-15       Impact factor: 5.590

4.  Creatine plus pyruvate supplementation prevents oxidative stress and phosphotransfer network disturbances in the brain of rats subjected to chemically-induced phenylketonuria.

Authors:  Vanessa Trindade Bortoluzzi; Letícia Brust; Thales Preissler; Itiane Diehl de Franceschi; Clovis Milton Duval Wannmacher
Journal:  Metab Brain Dis       Date:  2019-07-27       Impact factor: 3.584

5.  A Multiplatform Metabolomics Approach to Characterize Plasma Levels of Phenylalanine and Tyrosine in Phenylketonuria.

Authors:  H Blasco; C Veyrat-Durebex; M Bertrand; F Patin; F Labarthe; H Henique; P Emond; C R Andres; C Antar; C Landon; L Nadal-Desbarats; F Maillot
Journal:  JIMD Rep       Date:  2016-06-15

6.  Hyperphenylalaninemia Correlated with Global Decrease of Antioxidant Genes Expression in White Blood Cells of Adult Patients with Phenylketonuria.

Authors:  Charlotte Veyrat-Durebex; Christelle Debeissat; Hélène Blasco; Franck Patin; Hélène Henique; Patrick Emond; Catherine Antar; Valérie Gissot; Olivier Herault; François Maillot
Journal:  JIMD Rep       Date:  2017-03-15

7.  Inhibiting neutral amino acid transport for the treatment of phenylketonuria.

Authors:  Adam M Belanger; Malgorzata Przybylska; Estelle Gefteas; Matthew Furgerson; Sarah Geller; Alla Kloss; Seng H Cheng; Yunxiang Zhu; Nelson S Yew
Journal:  JCI Insight       Date:  2018-07-26

8.  Modeling the cognitive effects of diet discontinuation in adults with phenylketonuria (PKU) using pegvaliase therapy in PAH-deficient mice.

Authors:  Shelley R Winn; Sandra Dudley; Tanja Scherer; Nicole Rimann; Beat Thöny; Sydney Boutros; Destine Krenik; Jacob Raber; Cary O Harding
Journal:  Mol Genet Metab       Date:  2022-03-21       Impact factor: 4.204

9.  A Retrospective Case Series Analysis of the Relationship Between Phenylalanine: Tyrosine Ratio and Cerebral Glucose Metabolism in Classical Phenylketonuria and Hyperphenylalaninemia.

Authors:  Colm J McGinnity; Daniela A Riaño Barros; Eric Guedj; Nadine Girard; Christopher Symeon; Helen Walker; Sally F Barrington; Mary Summers; Mervi Pitkanen; Yusof Rahman
Journal:  Front Neurosci       Date:  2021-06-17       Impact factor: 4.677

10.  Disruption of phenylalanine hydroxylase reduces adult lifespan and fecundity, and impairs embryonic development in parthenogenetic pea aphids.

Authors:  Pierre Simonet; Karen Gaget; Nicolas Parisot; Gabrielle Duport; Marjolaine Rey; Gérard Febvay; Hubert Charles; Patrick Callaerts; Stefano Colella; Federica Calevro
Journal:  Sci Rep       Date:  2016-10-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.